Tricks of the TradeTrump's Second TermMy EconomyI've Always Wondered ...

Loading...

0:00
0% played
Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!
Stories Tagged as

Cancer

Bayer reaches $10 billion settlement in Roundup cancer lawsuits

by David Brancaccio , Scott Tong and Alex Schroeder
Jun 25, 2020
Bayer, which acquired Monsanto, the maker of Roundup, is trying to settle all claims, present and future.
The herbicide Roundup has been a blockbuster weedkiller, but plaintiffs say it causes a certain cancer and several juries have agreed.
Josh Edelson/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Drug shortages continue to affect common meds

by Sasa Woodruff
Mar 6, 2019
Contaminated supply chains, natural disasters, and the bottom line are just some of the reasons why basic drugs are in constant shortage.
Contaminated supply chains, natural disasters, and the bottom line are just some of the reasons why basic drugs are in constant shortage. 
Feverpitched/iStock/Getty Images Plus
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Cancer death rates have fallen 27 percent

by Andy Uhler
Jan 9, 2019
Oncology experts say advances in cancer drugs have played a major role.
Cathy Bradley says many cancer patients stay at work because they need the health insurance their employer provides.
Justin Sullivan/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

The EPA says TCE causes cancer, so why hasn't it been banned?

by Scott Tong
Jul 26, 2018
With the chemical industry challenging the cancer link, the agency has held off on action.
A view of the U.S. Environmental Protection Agency (EPA) headquarters on March 16, 2017 in Washington, DC. 
Justin Sullivan/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

The link between fracking and health issues

by Marketplace Contributor
Nov 15, 2017
Cause and effect can be difficult to prove, but here are a series of studies showing the potential connection between fracking and health risks.
A Cabot Oil & Gas natural gas drill stands at a hydraulic fracturing site in South Montrose, Pennsylvania. The process is controversial with critics who say it could poison water supplies, while the natural-gas industry says it's been used safely for decades.
Spencer Platt/Getty Images
Share Now on:
SHARE

More Americans are working through cancer

by Ryan Kailath
Jul 27, 2017
Sen. McCain is one out of millions of Americans who return to work after cancer treatment or diagnosis.
Cathy Bradley says many cancer patients stay at work because they need the health insurance their employer provides.
Justin Sullivan/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

This cancer patient is devoting his life to making drugs more affordable

by Dan Gorenstein
May 17, 2017
David Mitchell's advocacy group aims to bring down prescription prices by harnessing the power of patient stories.
Advocate David Mitchell says drugs are so expensive that some people are losing their homes or using college savings. Above, chemotherapy drugs.
Chris Hondros/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

For public good, not for profit.

Donate

U.S.-Cuba relations could be big for pharmaceuticals

by Andy Uhler
Jan 10, 2017
A "refreeze" could jeopardize cooperation on cancer drugs.
Cubans buy medicine in a drugstore in Havana.
STR/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Prostate cancer treatments in question

by Dan Gorenstein
Sep 26, 2016
To treat or not to treat; that is the question.
FREDERICK FLORIN/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Deals aimed at reining in costs of cancer drugs show promise

by Dan Gorenstein
Jun 6, 2016
Some manufacturers are willing to tie drug price to performance.
Dr. Julie Brahmer (R) and Katie Thornton review PET (Positron Emission Tomography) scans of a patient being treated at the Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, Maryland. 
Win McNamee/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE